Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Radioligands Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Beta-emitting
1.2.3 Targeted Alpha Therapy
1.3 Market by Application
1.3.1 Global Therapeutic Radioligands Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Solid Tumor
1.3.3 Non Hodgkin Lymphoma
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Radioligands Market Perspective (2018-2029)
2.2 Therapeutic Radioligands Growth Trends by Region
2.2.1 Global Therapeutic Radioligands Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Therapeutic Radioligands Historic Market Size by Region (2018-2024)
2.2.3 Therapeutic Radioligands Forecasted Market Size by Region (2024-2029)
2.3 Therapeutic Radioligands Market Dynamics
2.3.1 Therapeutic Radioligands Industry Trends
2.3.2 Therapeutic Radioligands Market Drivers
2.3.3 Therapeutic Radioligands Market Challenges
2.3.4 Therapeutic Radioligands Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Therapeutic Radioligands Players by Revenue
3.1.1 Global Top Therapeutic Radioligands Players by Revenue (2018-2024)
3.1.2 Global Therapeutic Radioligands Revenue Market Share by Players (2018-2024)
3.2 Global Therapeutic Radioligands Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Therapeutic Radioligands Revenue
3.4 Global Therapeutic Radioligands Market Concentration Ratio
3.4.1 Global Therapeutic Radioligands Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Radioligands Revenue in 2022
3.5 Therapeutic Radioligands Key Players Head office and Area Served
3.6 Key Players Therapeutic Radioligands Product Solution and Service
3.7 Date of Enter into Therapeutic Radioligands Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Radioligands Breakdown Data by Type
4.1 Global Therapeutic Radioligands Historic Market Size by Type (2018-2024)
4.2 Global Therapeutic Radioligands Forecasted Market Size by Type (2024-2029)
5 Therapeutic Radioligands Breakdown Data by Application
5.1 Global Therapeutic Radioligands Historic Market Size by Application (2018-2024)
5.2 Global Therapeutic Radioligands Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Therapeutic Radioligands Market Size (2018-2029)
6.2 North America Therapeutic Radioligands Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Therapeutic Radioligands Market Size by Country (2018-2024)
6.4 North America Therapeutic Radioligands Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Therapeutic Radioligands Market Size (2018-2029)
7.2 Europe Therapeutic Radioligands Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Therapeutic Radioligands Market Size by Country (2018-2024)
7.4 Europe Therapeutic Radioligands Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Radioligands Market Size (2018-2029)
8.2 Asia-Pacific Therapeutic Radioligands Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Therapeutic Radioligands Market Size by Region (2018-2024)
8.4 Asia-Pacific Therapeutic Radioligands Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Therapeutic Radioligands Market Size (2018-2029)
9.2 Latin America Therapeutic Radioligands Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Therapeutic Radioligands Market Size by Country (2018-2024)
9.4 Latin America Therapeutic Radioligands Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Radioligands Market Size (2018-2029)
10.2 Middle East & Africa Therapeutic Radioligands Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Therapeutic Radioligands Market Size by Country (2018-2024)
10.4 Middle East & Africa Therapeutic Radioligands Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Therapeutic Radioligands Introduction
11.1.4 Bayer Revenue in Therapeutic Radioligands Business (2018-2024)
11.1.5 Bayer Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Therapeutic Radioligands Introduction
11.2.4 Novartis Revenue in Therapeutic Radioligands Business (2018-2024)
11.2.5 Novartis Recent Development
11.3 Lantheus
11.3.1 Lantheus Company Detail
11.3.2 Lantheus Business Overview
11.3.3 Lantheus Therapeutic Radioligands Introduction
11.3.4 Lantheus Revenue in Therapeutic Radioligands Business (2018-2024)
11.3.5 Lantheus Recent Development
11.4 Aurobindo Pharma
11.4.1 Aurobindo Pharma Company Detail
11.4.2 Aurobindo Pharma Business Overview
11.4.3 Aurobindo Pharma Therapeutic Radioligands Introduction
11.4.4 Aurobindo Pharma Revenue in Therapeutic Radioligands Business (2018-2024)
11.4.5 Aurobindo Pharma Recent Development
11.5 Mundipharma
11.5.1 Mundipharma Company Detail
11.5.2 Mundipharma Business Overview
11.5.3 Mundipharma Therapeutic Radioligands Introduction
11.5.4 Mundipharma Revenue in Therapeutic Radioligands Business (2018-2024)
11.5.5 Mundipharma Recent Development
11.6 China Isotope & Radiation
11.6.1 China Isotope & Radiation Company Detail
11.6.2 China Isotope & Radiation Business Overview
11.6.3 China Isotope & Radiation Therapeutic Radioligands Introduction
11.6.4 China Isotope & Radiation Revenue in Therapeutic Radioligands Business (2018-2024)
11.6.5 China Isotope & Radiation Recent Development
11.7 Curium Pharmaceuticals
11.7.1 Curium Pharmaceuticals Company Detail
11.7.2 Curium Pharmaceuticals Business Overview
11.7.3 Curium Pharmaceuticals Therapeutic Radioligands Introduction
11.7.4 Curium Pharmaceuticals Revenue in Therapeutic Radioligands Business (2018-2024)
11.7.5 Curium Pharmaceuticals Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Detail
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Therapeutic Radioligands Introduction
11.8.4 Gilead Sciences Revenue in Therapeutic Radioligands Business (2018-2024)
11.8.5 Gilead Sciences Recent Development
11.9 Clarity Pharmaceuticals
11.9.1 Clarity Pharmaceuticals Company Detail
11.9.2 Clarity Pharmaceuticals Business Overview
11.9.3 Clarity Pharmaceuticals Therapeutic Radioligands Introduction
11.9.4 Clarity Pharmaceuticals Revenue in Therapeutic Radioligands Business (2018-2024)
11.9.5 Clarity Pharmaceuticals Recent Development
11.10 Curasight
11.10.1 Curasight Company Detail
11.10.2 Curasight Business Overview
11.10.3 Curasight Therapeutic Radioligands Introduction
11.10.4 Curasight Revenue in Therapeutic Radioligands Business (2018-2024)
11.10.5 Curasight Recent Development
11.11 Nordic Nanovector
11.11.1 Nordic Nanovector Company Detail
11.11.2 Nordic Nanovector Business Overview
11.11.3 Nordic Nanovector Therapeutic Radioligands Introduction
11.11.4 Nordic Nanovector Revenue in Therapeutic Radioligands Business (2018-2024)
11.11.5 Nordic Nanovector Recent Development
11.12 Philogen
11.12.1 Philogen Company Detail
11.12.2 Philogen Business Overview
11.12.3 Philogen Therapeutic Radioligands Introduction
11.12.4 Philogen Revenue in Therapeutic Radioligands Business (2018-2024)
11.12.5 Philogen Recent Development
11.13 RadioMedix
11.13.1 RadioMedix Company Detail
11.13.2 RadioMedix Business Overview
11.13.3 RadioMedix Therapeutic Radioligands Introduction
11.13.4 RadioMedix Revenue in Therapeutic Radioligands Business (2018-2024)
11.13.5 RadioMedix Recent Development
11.14 Telix Pharmaceuticals
11.14.1 Telix Pharmaceuticals Company Detail
11.14.2 Telix Pharmaceuticals Business Overview
11.14.3 Telix Pharmaceuticals Therapeutic Radioligands Introduction
11.14.4 Telix Pharmaceuticals Revenue in Therapeutic Radioligands Business (2018-2024)
11.14.5 Telix Pharmaceuticals Recent Development
11.15 Orano Med
11.15.1 Orano Med Company Detail
11.15.2 Orano Med Business Overview
11.15.3 Orano Med Therapeutic Radioligands Introduction
11.15.4 Orano Med Revenue in Therapeutic Radioligands Business (2018-2024)
11.15.5 Orano Med Recent Development
11.16 Actinium Pharmaceuticals
11.16.1 Actinium Pharmaceuticals Company Detail
11.16.2 Actinium Pharmaceuticals Business Overview
11.16.3 Actinium Pharmaceuticals Therapeutic Radioligands Introduction
11.16.4 Actinium Pharmaceuticals Revenue in Therapeutic Radioligands Business (2018-2024)
11.16.5 Actinium Pharmaceuticals Recent Development
11.17 Y-mAbs Therapeutics
11.17.1 Y-mAbs Therapeutics Company Detail
11.17.2 Y-mAbs Therapeutics Business Overview
11.17.3 Y-mAbs Therapeutics Therapeutic Radioligands Introduction
11.17.4 Y-mAbs Therapeutics Revenue in Therapeutic Radioligands Business (2018-2024)
11.17.5 Y-mAbs Therapeutics Recent Development
11.18 Fusion Pharmaceuticals
11.18.1 Fusion Pharmaceuticals Company Detail
11.18.2 Fusion Pharmaceuticals Business Overview
11.18.3 Fusion Pharmaceuticals Therapeutic Radioligands Introduction
11.18.4 Fusion Pharmaceuticals Revenue in Therapeutic Radioligands Business (2018-2024)
11.18.5 Fusion Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Therapeutic Radioligands Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Beta-emitting
Table 3. Key Players of Targeted Alpha Therapy
Table 4. Global Therapeutic Radioligands Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Therapeutic Radioligands Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Therapeutic Radioligands Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Therapeutic Radioligands Market Share by Region (2018-2024)
Table 8. Global Therapeutic Radioligands Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Therapeutic Radioligands Market Share by Region (2024-2029)
Table 10. Therapeutic Radioligands Market Trends
Table 11. Therapeutic Radioligands Market Drivers
Table 12. Therapeutic Radioligands Market Challenges
Table 13. Therapeutic Radioligands Market Restraints
Table 14. Global Therapeutic Radioligands Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Therapeutic Radioligands Market Share by Players (2018-2024)
Table 16. Global Top Therapeutic Radioligands Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Radioligands as of 2022)
Table 17. Ranking of Global Top Therapeutic Radioligands Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Therapeutic Radioligands Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Therapeutic Radioligands Product Solution and Service
Table 21. Date of Enter into Therapeutic Radioligands Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Therapeutic Radioligands Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Therapeutic Radioligands Revenue Market Share by Type (2018-2024)
Table 25. Global Therapeutic Radioligands Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Therapeutic Radioligands Revenue Market Share by Type (2024-2029)
Table 27. Global Therapeutic Radioligands Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Therapeutic Radioligands Revenue Market Share by Application (2018-2024)
Table 29. Global Therapeutic Radioligands Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Therapeutic Radioligands Revenue Market Share by Application (2024-2029)
Table 31. North America Therapeutic Radioligands Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Therapeutic Radioligands Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Therapeutic Radioligands Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Therapeutic Radioligands Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Therapeutic Radioligands Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Therapeutic Radioligands Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Therapeutic Radioligands Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Therapeutic Radioligands Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Therapeutic Radioligands Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Therapeutic Radioligands Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Therapeutic Radioligands Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Therapeutic Radioligands Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Therapeutic Radioligands Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Therapeutic Radioligands Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Therapeutic Radioligands Market Size by Country (2024-2029) & (US$ Million)
Table 46. Bayer Company Detail
Table 47. Bayer Business Overview
Table 48. Bayer Therapeutic Radioligands Product
Table 49. Bayer Revenue in Therapeutic Radioligands Business (2018-2024) & (US$ Million)
Table 50. Bayer Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Therapeutic Radioligands Product
Table 54. Novartis Revenue in Therapeutic Radioligands Business (2018-2024) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Lantheus Company Detail
Table 57. Lantheus Business Overview
Table 58. Lantheus Therapeutic Radioligands Product
Table 59. Lantheus Revenue in Therapeutic Radioligands Business (2018-2024) & (US$ Million)
Table 60. Lantheus Recent Development
Table 61. Aurobindo Pharma Company Detail
Table 62. Aurobindo Pharma Business Overview
Table 63. Aurobindo Pharma Therapeutic Radioligands Product
Table 64. Aurobindo Pharma Revenue in Therapeutic Radioligands Business (2018-2024) & (US$ Million)
Table 65. Aurobindo Pharma Recent Development
Table 66. Mundipharma Company Detail
Table 67. Mundipharma Business Overview
Table 68. Mundipharma Therapeutic Radioligands Product
Table 69. Mundipharma Revenue in Therapeutic Radioligands Business (2018-2024) & (US$ Million)
Table 70. Mundipharma Recent Development
Table 71. China Isotope & Radiation Company Detail
Table 72. China Isotope & Radiation Business Overview
Table 73. China Isotope & Radiation Therapeutic Radioligands Product
Table 74. China Isotope & Radiation Revenue in Therapeutic Radioligands Business (2018-2024) & (US$ Million)
Table 75. China Isotope & Radiation Recent Development
Table 76. Curium Pharmaceuticals Company Detail
Table 77. Curium Pharmaceuticals Business Overview
Table 78. Curium Pharmaceuticals Therapeutic Radioligands Product
Table 79. Curium Pharmaceuticals Revenue in Therapeutic Radioligands Business (2018-2024) & (US$ Million)
Table 80. Curium Pharmaceuticals Recent Development
Table 81. Gilead Sciences Company Detail
Table 82. Gilead Sciences Business Overview
Table 83. Gilead Sciences Therapeutic Radioligands Product
Table 84. Gilead Sciences Revenue in Therapeutic Radioligands Business (2018-2024) & (US$ Million)
Table 85. Gilead Sciences Recent Development
Table 86. Clarity Pharmaceuticals Company Detail
Table 87. Clarity Pharmaceuticals Business Overview
Table 88. Clarity Pharmaceuticals Therapeutic Radioligands Product
Table 89. Clarity Pharmaceuticals Revenue in Therapeutic Radioligands Business (2018-2024) & (US$ Million)
Table 90. Clarity Pharmaceuticals Recent Development
Table 91. Curasight Company Detail
Table 92. Curasight Business Overview
Table 93. Curasight Therapeutic Radioligands Product
Table 94. Curasight Revenue in Therapeutic Radioligands Business (2018-2024) & (US$ Million)
Table 95. Curasight Recent Development
Table 96. Nordic Nanovector Company Detail
Table 97. Nordic Nanovector Business Overview
Table 98. Nordic Nanovector Therapeutic Radioligands Product
Table 99. Nordic Nanovector Revenue in Therapeutic Radioligands Business (2018-2024) & (US$ Million)
Table 100. Nordic Nanovector Recent Development
Table 101. Philogen Company Detail
Table 102. Philogen Business Overview
Table 103. Philogen Therapeutic Radioligands Product
Table 104. Philogen Revenue in Therapeutic Radioligands Business (2018-2024) & (US$ Million)
Table 105. Philogen Recent Development
Table 106. RadioMedix Company Detail
Table 107. RadioMedix Business Overview
Table 108. RadioMedix Therapeutic Radioligands Product
Table 109. RadioMedix Revenue in Therapeutic Radioligands Business (2018-2024) & (US$ Million)
Table 110. RadioMedix Recent Development
Table 111. Telix Pharmaceuticals Company Detail
Table 112. Telix Pharmaceuticals Business Overview
Table 113. Telix Pharmaceuticals Therapeutic Radioligands Product
Table 114. Telix Pharmaceuticals Revenue in Therapeutic Radioligands Business (2018-2024) & (US$ Million)
Table 115. Telix Pharmaceuticals Recent Development
Table 116. Orano Med Company Detail
Table 117. Orano Med Business Overview
Table 118. Orano Med Therapeutic Radioligands Product
Table 119. Orano Med Revenue in Therapeutic Radioligands Business (2018-2024) & (US$ Million)
Table 120. Orano Med Recent Development
Table 121. Actinium Pharmaceuticals Company Detail
Table 122. Actinium Pharmaceuticals Business Overview
Table 123. Actinium Pharmaceuticals Therapeutic Radioligands Product
Table 124. Actinium Pharmaceuticals Revenue in Therapeutic Radioligands Business (2018-2024) & (US$ Million)
Table 125. Actinium Pharmaceuticals Recent Development
Table 126. Y-mAbs Therapeutics Company Detail
Table 127. Y-mAbs Therapeutics Business Overview
Table 128. Y-mAbs Therapeutics Therapeutic Radioligands Product
Table 129. Y-mAbs Therapeutics Revenue in Therapeutic Radioligands Business (2018-2024) & (US$ Million)
Table 130. Y-mAbs Therapeutics Recent Development
Table 131. Fusion Pharmaceuticals Company Detail
Table 132. Fusion Pharmaceuticals Business Overview
Table 133. Fusion Pharmaceuticals Therapeutic Radioligands Product
Table 134. Fusion Pharmaceuticals Revenue in Therapeutic Radioligands Business (2018-2024) & (US$ Million)
Table 135. Fusion Pharmaceuticals Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Therapeutic Radioligands Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Therapeutic Radioligands Market Share by Type: 2022 VS 2029
Figure 3. Beta-emitting Features
Figure 4. Targeted Alpha Therapy Features
Figure 5. Global Therapeutic Radioligands Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global Therapeutic Radioligands Market Share by Application: 2022 VS 2029
Figure 7. Solid Tumor Case Studies
Figure 8. Non Hodgkin Lymphoma Case Studies
Figure 9. Therapeutic Radioligands Report Years Considered
Figure 10. Global Therapeutic Radioligands Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Therapeutic Radioligands Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Therapeutic Radioligands Market Share by Region: 2022 VS 2029
Figure 13. Global Therapeutic Radioligands Market Share by Players in 2022
Figure 14. Global Top Therapeutic Radioligands Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Radioligands as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Therapeutic Radioligands Revenue in 2022
Figure 16. North America Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Therapeutic Radioligands Market Share by Country (2018-2029)
Figure 18. United States Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Therapeutic Radioligands Market Share by Country (2018-2029)
Figure 22. Germany Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Therapeutic Radioligands Market Share by Region (2018-2029)
Figure 30. China Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Therapeutic Radioligands Market Share by Country (2018-2029)
Figure 38. Mexico Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Therapeutic Radioligands Market Share by Country (2018-2029)
Figure 42. Turkey Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Therapeutic Radioligands Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Bayer Revenue Growth Rate in Therapeutic Radioligands Business (2018-2024)
Figure 45. Novartis Revenue Growth Rate in Therapeutic Radioligands Business (2018-2024)
Figure 46. Lantheus Revenue Growth Rate in Therapeutic Radioligands Business (2018-2024)
Figure 47. Aurobindo Pharma Revenue Growth Rate in Therapeutic Radioligands Business (2018-2024)
Figure 48. Mundipharma Revenue Growth Rate in Therapeutic Radioligands Business (2018-2024)
Figure 49. China Isotope & Radiation Revenue Growth Rate in Therapeutic Radioligands Business (2018-2024)
Figure 50. Curium Pharmaceuticals Revenue Growth Rate in Therapeutic Radioligands Business (2018-2024)
Figure 51. Gilead Sciences Revenue Growth Rate in Therapeutic Radioligands Business (2018-2024)
Figure 52. Clarity Pharmaceuticals Revenue Growth Rate in Therapeutic Radioligands Business (2018-2024)
Figure 53. Curasight Revenue Growth Rate in Therapeutic Radioligands Business (2018-2024)
Figure 54. Nordic Nanovector Revenue Growth Rate in Therapeutic Radioligands Business (2018-2024)
Figure 55. Philogen Revenue Growth Rate in Therapeutic Radioligands Business (2018-2024)
Figure 56. RadioMedix Revenue Growth Rate in Therapeutic Radioligands Business (2018-2024)
Figure 57. Telix Pharmaceuticals Revenue Growth Rate in Therapeutic Radioligands Business (2018-2024)
Figure 58. Orano Med Revenue Growth Rate in Therapeutic Radioligands Business (2018-2024)
Figure 59. Actinium Pharmaceuticals Revenue Growth Rate in Therapeutic Radioligands Business (2018-2024)
Figure 60. Y-mAbs Therapeutics Revenue Growth Rate in Therapeutic Radioligands Business (2018-2024)
Figure 61. Fusion Pharmaceuticals Revenue Growth Rate in Therapeutic Radioligands Business (2018-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed